The Discounted Cash Flow (DCF) valuation of Suven Pharmaceuticals Ltd (SUVENPHAR.NS) is 267.84 INR. With the latest stock price at 1,010.20 INR, the upside of Suven Pharmaceuticals Ltd based on DCF is -73.5%.
Based on the latest price of 1,010.20 INR and our DCF valuation, Suven Pharmaceuticals Ltd (SUVENPHAR.NS) is a sell. selling SUVENPHAR.NS stocks now will result in a potential gain of 73.5%.
| Range | Selected | |
| WACC / Discount Rate | 13.2% - 15.2% | 14.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 227.52 - 328.04 | 267.84 |
| Upside | -77.5% - -67.5% | -73.5% |